{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:56:57Z","timestamp":1762005417737,"version":"3.40.5"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Oromia Regional Health Bureau","award":["BEFO\/ABFH-D\/1543"],"award-info":[{"award-number":["BEFO\/ABFH-D\/1543"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Severe Acute Respiratory Syndrome (SARS COV-2) known as COVID-19 since its outbreak in 2019, more than 375 and 5.6 million were infected and dead, respectively. Its influence in all disciplines stimulated different industries to work day to night relentlessly to develop safe and effective vaccines to reduce the catastrophic effect of the disease. With the increasing number of people globally who have been vaccinated, the reports on possible adverse events have grown and gained great public attention. This study aims to determine post-COVID-19 vaccination adverse effects and associated factors among vaccinated Health care providers in the Oromia region, Ethiopia in 2021.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A cross-sectional study was conducted among 912 health care workers working in government hospitals in the central Oromia region from November 20 to December 15\/2021. Respondents absent from work due to different reasons were excluded during the interview. The outcome variable was COVID-19 side effects (response as Yes\/No). A descriptive analysis displayed findings in the form of the frequencies and percentages, and logistic regression was employed to see the association of different variables with side effects experienced.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Result<\/jats:title>\n<jats:p>Overall, 92.1% of the participants experienced side effects either in 1st or 2nd doses of post-COVID-19 vaccination; 84.0% and (71.5%) of participants experienced at least one side effect in the 1st and 2nd dose of the vaccines, respectively. COVID-19 infection preventive protocols like keeping distance, hand wash using soap, wearing mask and using sanitizer were decreased post vaccination. About 74.3% of the respondents were worried about the adverse effects of the COVID-19 vaccine they received. The majority (80.2%) of the respondent felt fear while receiving the vaccine and 22.5% of the respondents suspect the effectiveness of the vaccine they took. About 14.8% of the vaccinated Health workers were infected by COVID-19 post-vaccination. Engaging in moderate physical activity and feeling fear when vaccinated were the independent factors associated with reported side effects of post-COVID-19 vaccination using multiple logistic regression. Respondents who did not engage in physical activity were 7.54 fold more likely to develop post-COVID-19 vaccination side effects compared to those who involved at least moderate-intensity physical activity[AOR = 7.54, 95% CI;2.46,23.12]. The odds of experiencing side effects among the respondents who felt fear when vaccinated were 10.73 times compared not felt fear (AOR = 10.73, 95% CI; 2.47,46.64), and similarly, those who felt little fear were 4.28 times more likely to experience side effects(AOR = 4.28, 95% CI; 1.28, 14.39).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Significant numbers of the respondents experienced side effects post COVID-19 vaccination. It is recommended to provide pre-awareness about the side effects to reduce observed anxiety related to the vaccine. It is also important to plan monitoring and evaluation of the post-vaccine effect using standard longitudinal study designs to measure the effects directly.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0278334","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T18:34:00Z","timestamp":1670524440000},"page":"e0278334","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Post COVID-19 vaccination side effects and associated factors among vaccinated health care providers in Oromia region, Ethiopia in 2021"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5082-484X","authenticated-orcid":true,"given":"Mesfin Tafa","family":"Segni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailu Fekadu","family":"Demissie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammedawel Kaso","family":"Adem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adem Kedir","family":"Geleto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesfin Wubishet","family":"Kelkile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birhanu Kenate","family":"Sori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melese Lemmi","family":"Heyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhabesa Gobena","family":"Iticha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemechu Shumi","family":"Bejiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abera Botere","family":"Guddisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadeta Ayana","family":"Sima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lemessa Tadesse","family":"Amente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dereje Abdena","family":"Bayisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengistu Bekele","family":"Hurisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tesfaye Kebebew","family":"Jiru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"pone.0278334.ref001","unstructured":"Johns Hopkins Coronavirus Resource Center. COVID-19 dashboard. https:\/\/coronavirus.jhu.edu\/map.html. Accessed 10\/10\/2021."},{"key":"pone.0278334.ref002","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/biology10080752","article-title":"Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers","volume":"10","author":"M. Klugar","year":"2021","journal-title":"Biology"},{"key":"pone.0278334.ref003","unstructured":"UNDP: COVID 19 UNDP\u2019s Integrated Response 2020."},{"key":"pone.0278334.ref004","unstructured":"World Bank. COVID-19 to add as many as 150 million extreme poor by 2021 World Bank. https:\/\/www.worldbank.org\/en\/news\/press-release\/2020\/10\/07\/covid-19-to-add-as-many-as-150-million-extreme-poor-by-2021."},{"issue":"6486","key":"pone.0278334.ref005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1126\/science.368.6486.14","article-title":"Vaccine designers take first shots at COVID-19","volume":"368","author":"J. Cohen","year":"2020","journal-title":"Science"},{"key":"pone.0278334.ref006","unstructured":"COVID-19 vaccine development pipeline [https:\/\/vac-lshtm.shinyapps.io\/ncov_vaccine_landscape\/]."},{"key":"pone.0278334.ref007","unstructured":"R&D Blue Print. Draft landscape of COVID-19 candidate vaccines. Geneva:World Health Organization; 2020."},{"key":"pone.0278334.ref008","unstructured":"Different COVID-19 Vaccines | CDC. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines.html 2020."},{"key":"pone.0278334.ref009","unstructured":"The push for a COVID-19 vaccine. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/covid-19-vaccines?gclid=Cj0KCQjw2or8BRCNARIsAC_ppyYWO0oDbvpd9sqLLJWdKFEjk55hNRAllDrsejAc9bXJtb4lzTWr5F8aAoa8EALw_wcB."},{"key":"pone.0278334.ref010","unstructured":"More Than 12 Million Shots Given: Covid-19 Vaccine Tracker. https:\/\/www.bloomberg.com\/graphics\/covid-vaccine-trackerglobal-distribution\/."},{"key":"pone.0278334.ref011","first-page":"1","article-title":"Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination","volume":"27","author":"MA Haimei","year":"2021","journal-title":"Clinical and Applied Thrombosis\/ Hemostasis"},{"issue":"27","key":"pone.0278334.ref012","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"C4591001 Clinical Trial Group","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0278334.ref013","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"COVE Study Group","year":"2021","journal-title":"N Engl J Med"},{"issue":"10256","key":"pone.0278334.ref014","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S0140-6736(20)31960-7","article-title":"Safety and efficacy of the Russian COVID-19 vaccine: more information needed","volume":"396","author":"E Bucci","year":"2020","journal-title":"Lancet"},{"issue":"10269","key":"pone.0278334.ref015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(20)32623-4","article-title":"Oxford-AstraZeneca COVID-19 vaccine efficacy","volume":"397","author":"MD Knoll","year":"2021","journal-title":"Lancet"},{"issue":"20","key":"pone.0278334.ref016","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa2103055","article-title":"Efficacy of NVX-CoV2373 covid-19 vaccine against the B.1.351 variant","volume":"384","author":"2019nCoV-501 Study Group","year":"2021","journal-title":"N Engl J Med"},{"key":"pone.0278334.ref017","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against covid-19","volume":"384","author":"ENSEMBLE Study Group","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0278334.ref018","doi-asserted-by":"crossref","first-page":"12522","DOI":"10.1021\/acsnano.0c07197","article-title":"COVID-19 Vaccine frontrunners and their nanotechnology design","volume":"14","author":"YH Chung","year":"2020","journal-title":"ACS Nano"},{"key":"pone.0278334.ref019","unstructured":"Vaccines and immunization. https:\/\/www.who.int\/healthtopics\/vaccines-and-immunization?gclid=Cj0KCQjw2or8BRCNARIsAC_ppyZIpSAUsqJtN6zatE-G_pjHFu7IaD7d4WvtsYoA1bV_Xh1ntb6hRxUaAnv2EALw_wcB#tab=tab_1."},{"key":"pone.0278334.ref020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fmicb.2020.00372","article-title":"Vaccine safety: Myths and misinformation","volume":"11","author":"S Geoghegan","year":"2020","journal-title":"Front Microbiol"},{"key":"pone.0278334.ref021","unstructured":"Swine flu vaccine \u201clink\u201d to \u201cdeadly\u201d nerve condition\u2014NHS. https:\/\/www.nhs.uk\/news\/medication\/swine-flu-vaccine-link-todeadly-nerve-condition\/."},{"key":"pone.0278334.ref022","first-page":"664179","article-title":"Challenges and issues of anti-SARSCoV-2vaccines","volume":"8","author":"S Blumental","year":"2021","journal-title":"FrontMed (Lausanne)"},{"key":"pone.0278334.ref023","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/vaccines9060674","article-title":"Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia","volume":"9","author":"A. Alhazmi","year":"2021","journal-title":"Vaccines"},{"key":"pone.0278334.ref024","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2147\/PPA.S330689","article-title":"Evaluation of Post-Vaccination Symptoms of Two Common COVID-19 Vaccines Used in Abha, Aseer Region, Kingdom of Saudi Arabia","volume":"15","author":"M Adam","year":"2021","journal-title":"Patient Preference and Adherence"},{"key":"pone.0278334.ref025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijid.2021.07.052","article-title":"Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia","volume":"110","author":"S Al Bahrani","year":"2021","journal-title":"International Journal of Infectious Diseases"},{"issue":"4","key":"pone.0278334.ref026","doi-asserted-by":"crossref","DOI":"10.3201\/eid2704.210016","article-title":"Postvaccination COVID-19 among Healthcare Workers, Israel","volume":"27","author":"S Amit","year":"2021","journal-title":"Emerging Infectious Diseases"},{"key":"pone.0278334.ref027","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/j.vaccine.2021.07.047","article-title":"Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine","volume":"39","author":"N Tissot","year":"2021","journal-title":"Vaccine"},{"key":"pone.0278334.ref028","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/ph14090873","article-title":"Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia","volume":"14","author":"A. Riad","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"44","key":"pone.0278334.ref029","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1016\/j.vaccine.2021.09.060","article-title":"Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021","volume":"39","author":"VN Tran","year":"2021","journal-title":"Vaccine"},{"key":"pone.0278334.ref030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"R A.K. Kadalia","year":"2021","journal-title":"International Journal of Infectious Diseases"},{"key":"pone.0278334.ref031","article-title":"Population projections for Ethiopia 2007\u20132037","author":"Central Statistical Agency of Ethiopia","year":"2013","journal-title":"Addis Ababa"},{"issue":"21","key":"pone.0278334.ref032","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.3346\/jkms.2021.36.e153","article-title":"Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea","volume":"36","author":"YW Lee","year":"2021","journal-title":"J Korean Med Sci"},{"key":"pone.0278334.ref033","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.vaccine.2021.11.082","article-title":"Correlation of Anti-SARS-CoV-2 S1-specific IgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers","volume":"40","author":"M Izak","year":"2022","journal-title":"Vaccine"},{"key":"pone.0278334.ref034","doi-asserted-by":"crossref","first-page":"108136","DOI":"10.1016\/j.intimp.2021.108136","article-title":"Adverse events occurring post-covid-19 vaccination among healthcare professionals\u2013A mixed method study","volume":"100","author":"S Mahapatra","year":"2021","journal-title":"International Immunopharmacology"},{"key":"pone.0278334.ref035","article-title":"Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study","author":"JA Esquivel-Valerio","year":"2021","journal-title":"Rheumatology International"},{"key":"pone.0278334.ref036","doi-asserted-by":"crossref","first-page":"107098","DOI":"10.1016\/j.dib.2021.107098","article-title":"Survey data of COVID-19 vaccine side effects among hospital staff in a national referral hospital in Indonesia","volume":"36","author":"D Djanas","year":"2021","journal-title":"Data in Brief"},{"key":"pone.0278334.ref037","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijid.2021.08.013","article-title":"Side effects and perceptions following Sinopharm COVID-19 vaccination","volume":"111","author":"BQ Saeed","year":"2021","journal-title":"International Journal of Infectious Diseases"},{"key":"pone.0278334.ref038","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/vaccines9060556","article-title":"Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects","volume":"9","author":"M.M. Hatmal","year":"2021","journal-title":"Vaccines"},{"issue":"17","key":"pone.0278334.ref039","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3346\/jkms.2021.36.e115","article-title":"Adverse reactions following the first dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2Vaccine for healthcare workers in South Korea","volume":"36","author":"S Bae","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"2","key":"pone.0278334.ref040","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s40122-021-00296-3","article-title":"Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study","volume":"10","author":"CH G\u00f6bel","year":"2021","journal-title":"Pain Ther"},{"key":"pone.0278334.ref041","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"F.P. Polack","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"27","key":"pone.0278334.ref042","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.3346\/jkms.2021.36.e196","article-title":"Emergency Department Utilization by In-hospital Healthcare Workers after COVID-19 Vaccination","volume":"36","author":"MJ Park","year":"2021","journal-title":"J Korean Med Sci"},{"key":"pone.0278334.ref043","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.3390\/ijerph18126291","article-title":"Subjective Feelings of Polish Doctors after Receiving the COVID-19 Vaccine","volume":"18","author":"K. Zdziarski","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"pone.0278334.ref044","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jmv.27320","article-title":"Occurrence of COVID\u201019 in priority groups receiving ChAdOx1 nCoV\u201019 coronavirus vaccine (recombinant): A preliminary analysis from north India","volume":"94","author":"U Kaur","year":"2022","journal-title":"J Med Virol"},{"key":"pone.0278334.ref045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13690-021-00741-x","article-title":"Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021","volume":"79","author":"YR Konu","year":"2021","journal-title":"Archives of Public Health"},{"key":"pone.0278334.ref046","article-title":"Benefits of physical activity and physical exercise in the time of pandemic","volume":"12","author":"S Amatriain-Fern\u00e1ndez","journal-title":"Psychological Trauma 2020: Theory, Research, Practice, and Policy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T18:34:16Z","timestamp":1670524456000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278334"}},"subtitle":[],"editor":[{"given":"Mohd","family":"Adnan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0278334","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,12,8]]}}}